Segment Information (Tables)

9 Months Ended

Mar. 29, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Consumer Healthcare		Nutritionals		Rx Pharma-ceuticals		API		Specialty Sciences			Other		Unallocated expenses			Total(2)
Third Fiscal Quarter 2014
Net sales	$	537.3	$	137.8	$	223.4	$	32.0	$	53.4		$	20.2	$	—		$	1,004.2
Operating income      (loss)	$	84.4	$	7.3	$	77.0	$	6.8	$	(54.5	)	$	0.8	$	(18.5	)	$	103.3
Amortization of intangibles	$	5.3	$	7.3	$	17.5	$	0.5	$	76.4		$	0.4	$	—		$	107.4
Total assets	$	2,555.2	$	1,011.5	$	1,985.4	$	286.8	$	7,799.5		$	104.4	$	—		$	13,742.7
Third Fiscal Quarter 2013
Net sales	$	536.8	$	133.3	$	189.4	$	41.1	$	—		$	19.2	$	—		$	919.8
Operating income      (loss)	$	95.9	$	7.0	$	73.4	$	11.7	$	—		$	1.6	$	(11.1	)	$	178.6
Amortization of intangibles	$	5.0	$	7.3	$	11.4	$	0.5	$	—		$	0.4	$	—		$	24.6
Total assets	$	1,724.6	$	951.1	$	1,433.8	$	279.0	$	—		$	107.4	$	—		$	4,495.9

	Consumer Healthcare		Nutritionals		Rx Pharma-ceuticals		API		Specialty Sciences(1)			Other		Unallocated expenses			Total(2)
Year-to-Date Fiscal 2014
Net sales	$	1,612.1	$	406.6	$	673.6	$	105.2	$	60.8		$	58.3	$	—		$	2,916.6
Operating income      (loss)	$	263.8	$	28.3	$	260.5	$	37.4	$	(73.5	)	$	2.6	$	(149.7	)	$	369.5
Amortization of intangibles	$	15.9	$	22.1	$	55.2	$	1.6	$	85.0		$	1.3	$	—		$	181.1
Total assets	2,555.2		1,011.5		1,985.4		286.8		7,799.5			104.4		$	—		13,742.7
Year-to-Date Fiscal 2013
Net sales	$	1,526.5	$	358.7	$	514.9	$	118.4	$	—		$	54.1	$	—		$	2,572.6
Operating income      (loss)	$	261.3	$	18.0	$	206.0	$	38.9	$	—		$	2.7	$	(27.8	)	$	499.0
Amortization of intangibles	$	12.2	$	21.9	$	28.2	$	1.4	$	—		$	1.2	$	—		$	65.0
Total assets	$	1,724.6	$	951.1	$	1,433.8	$	279.0	$	—		$	107.4	$	—		$	4,495.9

⁽¹⁾    Specialty Sciences only includes activity from December 18, 2013 to March 29, 2014.

⁽²⁾Amounts may not cross-foot due to rounding.